Promega, One Lambda to Co-market DNA Extraction, Testing Systems | GenomeWeb
NEW YORK (GenomeWeb News) – Promega and One Lambda have agreed to co-market Promega’s DNA extraction systems with One Lambda’s human leukocyte antigen tests, Promega said yesterday.
 
Under the agreement, the companies will market the Promega Maxwell 16 DNA extraction system along with One Lambda’s LABType SSO and Micro SSP tests to customers in the HLA market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.